Jupiter Life Line Hospitals Limited (NSE:JLHL)
India · Delayed Price · Currency is INR | Market Cap | 87.01B -6.7% |
| Revenue (ttm) | 15.00B +18.9% |
| Net Income | 1.94B +0.3% |
| EPS | 29.59 +0.3% |
| Shares Out | 65.57M |
| PE Ratio | 44.85 |
| Forward PE | 38.50 |
| Dividend | 1.00 (0.08%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | 17,764 |
| Open | 1,340.00 |
| Previous Close | 1,327.10 |
| Day's Range | 1,299.70 - 1,340.00 |
| 52-Week Range | 1,178.00 - 1,625.00 |
| Beta | 0.16 |
| Analysts | Strong Buy |
| Price Target | 1,595.83 (+22.26%) |
| Earnings Date | May 15, 2026 |
About NSE:JLHL
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurger... [Read more]
Financial Performance
In fiscal year 2026, NSE:JLHL's revenue was 15.00 billion, an increase of 18.88% compared to the previous year's 12.62 billion. Earnings were 1.94 billion, an increase of 0.26%.
Financial StatementsNews
Jupiter Life Line Hospitals Transcript: Q4 25/26
FY 2026 saw strong 15%+ growth in revenue and EBITDA, with robust expansion plans adding 1,700 beds across Mumbai and Pune. Dombivli hospital opened ahead of schedule, and the group remains cash positive, funding growth through internal accruals and capped debt.
Jupiter Life Line Hospitals Quarterly report: Q4 2026
Jupiter Life Line Hospitals has published its Q4 2026 quarterly earnings report on May 18, 2026.
Jupiter Life Line Hospitals Slides: Q4 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.
Jupiter Life Line Hospitals Transcript: Q3 25/26
Q3 FY2026 saw 9.8% revenue growth and 9.2% EBITDA growth, but PAT declined 18.7% due to a one-time labor code provision. The new Dombivli hospital will initially weigh on margins, while mature hospitals maintain stable performance.
Jupiter Life Line Hospitals Quarterly report: Q3 2026
Jupiter Life Line Hospitals has published its Q3 2026 quarterly earnings report on February 1, 2026.
Jupiter Life Line Hospitals Slides: Q3 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 1, 2026.
Jupiter Life Line Hospitals Transcript: Q2 25/26
Q2 and H1 FY26 saw double-digit revenue and EBITDA growth, with strong ARPOB gains and ongoing hospital expansion. Margin dilution is expected as new hospitals come online, but long-term demand remains robust. Unbilled revenue and one-off provisions impacted reported results.
Jupiter Life Line Hospitals Quarterly report: Q2 2026
Jupiter Life Line Hospitals has published its Q2 2026 quarterly earnings report on November 10, 2025.
Jupiter Life Line Hospitals Slides: Q2 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 10, 2025.
Jupiter Life Line Hospitals Transcript: Q1 25/26
Q1 FY26 saw 20.5% revenue growth and 19.6% EBITDA growth, but PAT declined 1.6% due to higher depreciation and finance costs. Occupancy and patient volumes rose, with strong ARPOB growth from price hikes and case mix. Renewable energy investments and greenfield expansions continue.
Jupiter Life Line Hospitals Quarterly report: Q1 2026
Jupiter Life Line Hospitals has published its Q1 2026 quarterly earnings report on August 4, 2025.
Jupiter Life Line Hospitals Slides: Q1 2026
Jupiter Life Line Hospitals has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 4, 2025.